1. Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts. (14th October 2021) Authors: Sorrentino, A; Bagwan, N; Linscheid, N; Poulsen, P; Kahnert, K; Thomsen, M; Delmar, M; Lundby, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Loss-of-function variants in founder population highlight atrial myopathy as susceptibility to atrial fibrillation. (3rd October 2022) Authors: Paludan-Muller, C; Vad, O B; Kahnert, K; Ahlberg, G; Monfort, L M; Rand, S A; Trudsoe, L C; Andreasen, L; Christensen, A H; Bundgaard, H; Lundby, A; Svendsen, J H; Olesen, M S Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗